Managed Access Programs for ETB115, Eltrombopag
ConditionThrombocytopenia
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age18-99
SponsorNovartis Pharmaceuticals
About this trial
The purpose of this registration is to list Managed Access Programs (MAPs) related to ETB115, Eltrombopag
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Eltrombopag
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov